NEW MJ NEWS

AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-and-full-year-2021-earnings-conference-call-301451929.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$ENRT Gives New Burlington Update

Enertopia Provides Burlington MMPR Update VANCOUVER, BC / ACCESSWIRE / December 9,…

LoCo Adds Koios Beverage Corp. (KBEV) (KBEVF) to its Vendor Network

Local-Focused Foods Distributor LoCo Adds Koios to its Vendor Network, Providing Access…

AbbVie Inc. (ABBV) Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study

AbbVie’s Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an…